A Phase II Trial Evaluating Weekly Docetaxel and Capecitabine in Patients with Metastatic or Advanced, Locally Recurrent Head and Neck Cancers

Author： Zhang Jingsong   Lee Julia   Urba Susan   Foster Jared   Worden Francis  

Publisher： Informa Healthcare

ISSN： 0735-7907

Source： Cancer Investigation, Vol.28, Iss.9, 2010-10, pp. : 910-916

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase I/II study of docetaxel, cisplatin and S1 in locally advanced, recurrent and metastatic head and neck squamous cell carcinoma

By                      

Oncology Letters, Vol. 4, Iss. 5, 2012-01 ,pp. : 898-904

Spandidos Publications

Access to resources Recommend Favorite

Phase II studies on docetaxel alone every third week, or weekly in combination with gemcitabine in patients with primary locally advanced, metastatic, or recurrent esophageal cancer

By Albertsson M.   Johansson B.   Friesland S.   Kadar L.   Letocha H.   Frykholm G.   Wagenius G.  

Medical Oncology, Vol. 24, Iss. 4, 2007-12 ,pp. : 407-412

Humana Press, Inc

Access to resources Recommend Favorite

A Phase I Trial of Docetaxel Based Induction and Concomitant Chemotherapy in Patients with Locally Advanced Head and Neck Cancer

By Seiwert Tanguy   Cohen Ezra   Haraf Daniel   Stenson Kerstin   Blair Elizabeth   Mauer Ann   Dekker Allison   Vokes Everett  

Cancer Investigation, Vol. 25, Iss. 6, 2007-09 ,pp. : 435-444

Informa Healthcare

Access to resources Recommend Favorite

Phase I trial of combined chemotherapy with docetaxel, cisplatin, and 5-fluorouracil for patients with locally advanced squamous cell carcinoma of the head and neck

By Tsukuda Mamoru   Mikami Yasukazu   Tanigaki Yuji   Katori Hideaki   Horiuchi Choichi   Ikeda Yoichi   Taguchi Takahide   Ono Machiko   Yoshida Takahumi   Sakuma Yasunori   Aikoh Ken  

International Journal of Clinical Oncology, Vol. 9, Iss. 3, 2004-06 ,pp. : 161-166

Springer Publishing Company

Access to resources Recommend Favorite

Evaluation of the Combination of Docetaxel/Carboplatin in Patients with Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck (SCCHN): A Southwest Oncology Group Phase II Study

By Samlowski Wolfram E.   Moon James   Kuebler J. Philip   Nichols Craig R.   Gandara David R.   Ozer Howard   Williamson Stephen K.   Atkins James N.   Schuller David E.   Ensley John F.  

Cancer Investigation, Vol. 25, Iss. 3, 2007-04 ,pp. : 182-188

Informa Healthcare

Access to resources Recommend Favorite